The goal of this first-ever study, to be coordinated by Brigham and Women’s Hospital in Boston, is to evaluate the types of errors that may occur when using smart pumps to administer IV medications, and what can be done about them.
The study builds on prior work by AAMI related to infusion pumps, which have been linked to 56,000 adverse events and 710 patient deaths reported to the FDA between 2005 and 2009.
Related Articles on Device Safety:
Federal Agencies Issue Recommendation to Prevent Needlestick Injuries
Senate Passes FDA Safety and Innovation Act
No Literature? No Problem: Pioneering Infection Control Standards
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
